Results     02-May-19
Announcements
Ajanta Pharma consolidated net profit declines 5.93% in the March 2019 quarter
Sales decline 2.86% to Rs 515.16 crore
Net profit of Ajanta Pharma declined 5.93% to Rs 88.89 crore in the quarter ended March 2019 as against Rs 94.49 crore during the previous quarter ended March 2018. Sales declined 2.86% to Rs 515.16 crore in the quarter ended March 2019 as against Rs 530.31 crore during the previous quarter ended March 2018.

For the full year,net profit declined 17.43% to Rs 386.97 crore in the year ended March 2019 as against Rs 468.64 crore during the previous year ended March 2018. Sales declined 3.54% to Rs 2055.37 crore in the year ended March 2019 as against Rs 2130.86 crore during the previous year ended March 2018.

ParticularsQuarter EndedYear Ended
 Mar. 2019Mar. 2018% Var.Mar. 2019Mar. 2018% Var.
Sales515.16530.31 -3 2055.372130.86 -4
OPM %24.6726.31 -27.5630.90 -
PBDT127.94144.66 -12 586.35682.14 -14
PBT109.19128.02 -15 514.27622.55 -17
NP88.8994.49 -6 386.97468.64 -17

Previous News
  Stocks in focus: Ajanta Pharma, Zydus Lifesciences, HAL, L&T, Deccan Gold Mines
 ( Market Commentary - Stock Alert 08-Mar-23   08:32 )
  Ajanta Pharma to convene board meeting
 ( Corporate News - 20-Jan-24   12:12 )
  Ajanta Pharma announces board meeting date
 ( Corporate News - 07-Mar-23   09:37 )
  Volumes jump at Ajanta Pharma Ltd counter
 ( Hot Pursuit - 03-May-24   11:00 )
  Ajanta Pharma to conduct board meeting
 ( Corporate News - 22-Jan-22   12:21 )
  Ajanta Pharma standalone net profit declines 22.27% in the June 2022 quarter
 ( Results - Announcements 28-Jul-22   17:16 )
  Ajanta Pharma to declare Quarterly Result
 ( Corporate News - 02-May-22   12:34 )
  Ajanta Pharma to declare Quarterly Result
 ( Corporate News - 23-Jan-21   14:03 )
  Ajanta Pharma soars after board OKs Rs 285-cr buyback proposal
 ( Hot Pursuit - 28-Dec-21   12:55 )
  Ajanta Pharma consolidated net profit rises 64.23% in the December 2020 quarter
 ( Results - Announcements 02-Feb-21   17:50 )
  Board of Ajanta Pharma to consider buyback of shares
 ( Corporate News - 28-Oct-20   20:15 )
Other Stories
  Kronox Lab Sciences standalone net profit rises 140.98% in the March 2024 quarter
  29-Jun-24   07:31
  Performance Chemiserve standalone net profit rises 6062.22% in the March 2024 quarter
  27-Jun-24   07:24
  Sundew Properties standalone net profit rises 119.15% in the March 2024 quarter
  27-Jun-24   07:24
  IKF Home Finance standalone net profit rises 42.15% in the March 2024 quarter
  27-Jun-24   07:24
  Delhi Transco standalone net profit rises 1.08% in the March 2024 quarter
  27-Jun-24   07:24
  Profectus Capital Pvt standalone net profit rises 12.12% in the March 2024 quarter
  27-Jun-24   07:24
  Shrem Infra Invest Pvt consolidated net profit rises 290.12% in the March 2024 quarter
  27-Jun-24   07:24
  Bharat Ekansh reports consolidated net loss of Rs 0.01 crore in the March 2024 quarter
  27-Jun-24   07:24
  Patel KNR Heavy Infrastructures reports standalone net loss of Rs 2.71 crore in the March 2024 quarter
  27-Jun-24   07:24
  Supreme Infrastructure India reports consolidated net loss of Rs 326.26 crore in the March 2024 quarter
  26-Jun-24   07:29
Back Top